Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease

Laboratory Investigation

Volumn 92, Issue 8, 2012, Pages 1234-1245

  Ziehn, Marina O ^a,b   Avedisian, Andrea A ^b   Dervin, Shannon M ^b   O'Dell, Thomas J ^b   Voskuhl, Rhonda R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

EAE; estriol; hippocampus; MS; synaptic transmission

Indexed keywords

ESTRIOL; MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; CORRELATION ANALYSIS; FACILITATION; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; MOUSE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; STAINING; SYNAPTIC TRANSMISSION;

EID: 84864495474     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.76     Document Type: Article

References (75)

1. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139-1151.
2. Benedict RHB, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MCFIMS). J Int Neuropsychol Soc 2006;12:549-558.
3. Thornton AE, Raz N. Memory impairment in multiple sclerosis. Neuropsychology 1997;11:357-366.
4. Benedict RHB, Ramasamy D, Munschauer F, et al. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009;80:201-206.
5. Roosendaal SD, Moraal B, Vrenken H, et al. In vivo imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging 2008; 27:726-731.
6. Anderson VM, Fisniku LK, Khaleeli A, et al. Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study. Mult Scler 2010;16:1083-1090.
7. Sicotte NL, Kern KC, Giesser BS, et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2009;132:3072-3086.
8. Geurts JJ, Bo L, Roosendaal SD, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007;66: 819-827.
9. Papadopoulos D, Dukes S, Patel R, et al. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol 2009;19: 238-253.
10. Dutta R, Chang A, Doud MK, et al. Demyelination causes synaptic alterations in hippocampi from Multiple Sclerosis patients. Ann Neurol 2011;69:445-454.
11. Rasmussen S, Wang Y, Kivisakk P, et al. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing remitting experimental autoimmune encephalomyelitis. Brain 2007;130:2816-2829.
12. Crawford DK, Mangiardi M, Song B, et al. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 2010;133:2999-3016.
13. MacKenzie-Graham A, Tiwari-Woodruff SK, Sharma G, et al. Purkinje cell loss in experimental autoimmune encephalomyelitis. Neuroimage 2009;48:637-651.
14. Centonze D, Muzio L, Rossi S, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 2009;29:3442-3452.
15. Gold SM, Voskuhl RR. Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 2009;175:239-251.
16. Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancyrelated relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998;339:285-291.
17. Sicotte NL, Liva SM, Kluth R, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002;52:421-428.
18. Kim S, Liva SM, Dalal MA, et al. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 1999;52:1230-1238.
19. Bebo Jr BF, Fyfe-Johnson A, Adlard K, et al. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two difference inbred mouse strains. J Immunol 2001;166:2080-2089.
20. Morales LBJ, Loo KK, Liu HB, et al. Treatment with an estrogen receptor {alpha} ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 2006;26:6823-6833.
21. Tiwari-Woodruff S, Morales LBJ, Lee R, et al. Differential neuroprotective and anti-inflammatory effects of estrogen receptor (ER)a and ERb ligand treatment. Proc Natl Acad Sci USA 2007;104: 14813-14818.
22. Vetego E, Benedusi V, Maggi A. Estrogen anti-inflammatory activity in the brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol 2008;29:507-519.
23. Stein DG, Hoffman SW. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil 2003; 6:13-22.
24. Wise PM, Dubal DB, Rau SW, et al. Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's Health Initiative. Endocr Rev 2005;26:308-312.
25. Behl C, Skutella T, Lezoualch F, et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997;51:535-541.
26. Murphy DD, Cole NB, Greenberger V, et al. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci 1998;18:2550-2559.
27. Jover T, Tanaka H, Calderone A, et al. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J Neurosci 2002;22: 2115-2124.
28. Kretz O, Fester L, Wehrenberg U, et al. Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci 2004;24:5913-5921.
29. Toran-Allerand CD. Novel sites and mechanism of oestrogen action in the brain. Novartis Found Symp 2000;230:56-73.
30. Kramar EA, Chen LY, Brandon NJ, et al. Cytoskeletal changes underlie estrogen's acute effects on synaptic transmission and plasticity. J Neurosci 2009;29:12982-12993.
31. Yun SH, Park KA, Kwon S, et al. Estradiol enhances long-term potentiation in hippocampal slices from aged apoE4-TR mice. Hippocampus 2007;17:1153-1157.
32. Woolley CS. Effects of estrogen in the CNS. Curr Opin Neurobiol 1999;9:349-354.
33. Woolley CS. Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol 2007;47:657-680.
34. Ziehn MO, Avedisian AA, Tiwari-Woodruff S, et al. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab Invest 2010;90:774-786.
35. Pettinelli C, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2-T lymphocytes. J Immunol 1981;127:1420-1423.
36. Cuthbert PC, Stanford LA, Coba MP, et al. Synapse-associated protein 102/dlgh3 couples the NMDA receptor to specific plasticity pathways and learning strategies. J Neurosci 2007;27:2673-2682.
37. Komiyama NH, Watabe AM, Carlisle HJ, et al. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J Neurosci 2002;22: 9721-9732.
38. Wiltgen BJ, Royle GA, Gray EE, et al. A role for calcium-permeable AMPA receptors in synaptic plasticity and learning. PLoS One 2010; 5:pii e12818.
39. Paxinos G, Franklin KBJ. The Mouse Brain in Stereological Coordinates, 2nd edn Academic Press: San Diego, CA, 2001.
40. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987;147:229-263.
41. Cruz-Orive LM. Precision of Cavalieri sections and slices with local errors. J Microsc 1999;193:182-198.
42. Spence RD, Hamby ME, Umeda E, et al. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 2011;108:8867-8872.
43. Arezzo JC, Litwak MS, Zotova EG. Correlation and dissociation of electrophysiology and histopathology in the assessment of toxic neuropathy. Toxicol Pathol 2011;39:46-51.
44. Aubert S, Wendling F, Regis J, et al. Local and remote epileptogenicity in focal cortical dysplasias and neurodevelopmental tumours. Brain 2009;132:3072-3086.
45. Lehmann HC, Zhang J, Mori S, et al. Diffusion tensor imaging to assess axonal regeneration in peripheral nerves. Exp Neurol 2010;223: 238-244.
46. Palaszynski KM, Liu H, Loo KK, et al. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 2004;149:84-89.
47. Futai K, Kim MJ, Hashikawa T, et al. Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin. Nat Neurosci 2007;10:186-195.
48. Kuzumaki N, Ikegami D, Imai S, et al. Enhanced IL-1beta production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice. Synapse 2010;64:721-728.
49. Voskuhl RR, Peterson RS, Song B, et al. Reactive astrocytes form scarlike perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 2009;29:11511-11522.
50. Debanne D, Guerineau NC, Gahwiler BH, et al. Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. J Physiol 1996;15(Pt 1):163-176.
51. Dobrunz LE, Stevens CF. Heterogeneity of release probability, facilitation and depletion at central synapses. Neuron 1997;18: 995-1008.
52. Zucker RS, Regehr WG. Short-term synaptic plasticity. Annu Rev Physiol 2002;64:355-405.
53. Conti R, Lisman J. The high variance of AMPA receptor-and NMDA receptor-mediated responses at single hippocampal synapses: evidence for multi-quantal release. Proc Natl Acad Sci 2003;100: 4885-4890.
54. Dean C, Dresbach T. Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends Neurosci 2006;29: 21-29.
55. Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 2004;5:771-781.
56. Han K, Kim E. Synaptic adhesion molecules and PSD-95. Prog Neurobiol 2008;84:263-283.
57. Nguyen T, Sudhof TC. Binding properties of neuroligin 1 and neurexin 1beta reveal function as heterophilic cell adhesion molecules. J Biol Chem 1997;272:26032-26039.
58. Dean C, Scholl FG, Choih J, et al. Neurexin mediates the assembly of presynaptic terminals. Nat Neusci 2003;6:708-716.
59. Levinson JN, Chery N, Huang K, et al. Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1beta in neuroligin-induced synaptic specificity. J Biol Chem 2005;280:17312-17319.
60. Jelks KB, Wylie R, Floyd CL, et al. Estradiol targets synaptic proteins to induce glutamatergic synapse formation in cultured hippocampal neurons: critical role of estrogen receptor-alpha. J Neurosci 2007;27: 6903-6913.
61. Teyler TJ, Vardaris RM, Lewis D, et al. Gonadal steroids: effects on excitability of hippocampal pyramidal cells. Science 1980;209: 1017-1018.
62. Smejkalova T, Woolley CS. Estradiol acutely potentiates hippocampal excitatory synaptic transmission through a presynaptic mechanism. J Neurosci 2010;30:16137-16148.
63. Foy MR, Xu J, Xie X, et al. 17b-estradiol enhances NMDA receptormediated EPSPs and long-term potentiation. J Neurophysiol 1999; 81:925-929.
64. Li C, Brake WG, Romeo RD, et al. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc Natl Acad Sci USA 2004;101: 2185-2190.
65. Kang HS, Lee CK, Kim JR, et al Gene expression analysis of the prooestrous-stage rat uterus reveals neuroligin 2 as a novel steroidregulated gene. Reprod Fertil Dev 2004;16:763-772.
66. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001;63:29-60.
67. Carroll JC, Rosario ER, Chang L, et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 2007;27:13357-13365.
68. Pike CJ, Carroll JC, Rosario ER, et al. Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 2009;30: 239-258.
69. Voskuhl RR. 'Estrogens in the Treatment of MS' Multiple Sclerosis Therapeutics, 3rd edn Informa Healthcare: UK, 2007, pp 645-657.
70. Enmark E, Gustafsson JA. Oestrogen receptors-an overview. J Intern Med 1999;246:133-138.
71. Mehra RD, Sharma K, Nyakas C, et al. Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: a qualitative and quantitative study. Brain Res 2005; 1056:22-35.
72. Pfaff DW, Ribiero AC. Theoretical consequences of fluctuating versus constant liganding of oestrogen receptor-alpha in neurons. J Neuroendocrinol 2010;22:486-491.
73. Azcoitia I, Santos-Galindo M, Arevalo MA, et al. Role of astroglia in the neuroplastic and neuroprotective actions of estradiol. Eur J Neurosci 2010;32:1995-2002.
74. Arevalo MA, Santos-Galindo M, Bellini MJ, et al. Actions of estrogens on glial cells: implications for neuroprotection. Biochim Biophys Acta 2010;1800:1106-1112.
75. Mitterling KL, Spencer JL, Dziedzic N, et al. Cellular and subcellular localization of estrogen and progestin receptor immunoreactivities in the mouse hippocampus. J Comp Neurol 2010;518: 2729-2743.